Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary
Compounding Law; Health Care; Awareness of all Types of Compounding Issues;
Pharmacy Benefit Managers (PBMs), Outsourcing Facilities
Food and Drug Administration and Compliance Issues
Pages
▼
Tuesday, March 15, 2016
"[M]ajor shareholder Opaleye Management Inc. bought 45,000 shares of Imprimis Pharmaceuticals stock in a transaction on Friday, March 11th. The shares were bought at an average cost of $3.65 per share, with a total value of $164,250.00."
No comments:
Post a Comment